The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
Sang Hyun Shin(Ulsan College), Song Cheol Kim(Ulsan College), Eunsung Jun(Asan Medical Center), Young Joo Lee(Anne Arundel Medical Center), In Kyong Shim(Asan Medical Center), K Song(Ulsan College), Jae Hoon Lee(Ulsan College), Hyoung Jung Kim(Ulsan College), Kwang-Min Park(Ulsan College), Seung-Mo Hong(Ulsan College), Hwa Jung Kim(Ulsan College), Hwa Jung Kim(Ulsan College), Dae Wook Hwang(Asan Medical Center)
Cited by 54
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260